Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne Inc. has demonstrated impressive growth metrics, achieving a revenue increase of 117% year-over-year in its first quarter as a public company, along with a positive net income of $1.5 million, indicating a strong turnaround in financial performance. The company has also experienced significant margin expansion, with gross margins rising to 53.0%, reflecting effective scaling and operational efficiencies. Furthermore, the strong demand for its product offerings, particularly in prenatal and oncology testing, positions BillionToOne for a projected compound annual growth rate (CAGR) of over 25% in revenue, supported by an increasing test volume per patient.

Bears say

BillionToOne Inc faces significant risks that could adversely affect its financial performance, primarily stemming from a potential weakening of its competitive position if proprietary technologies are not adequately protected. The company may experience slower revenue growth due to shifting market share within its core prenatal testing business and challenges in gaining traction with newer oncology products, compounded by higher denial rates from payers concerning the efficacy of its tests. Additionally, there are concerns regarding reimbursement rates from Medicare and state Medicaid programs, which could further negatively impact BillionToOne's overall revenue and profitability.

Billiontoone Inc (BLLN) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 7 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.